John Mandrola, MD, FACC

All posts by John Mandrola, MD, FACC

RSS

April 5th, 2012

When the Feds Come Knocking

and

CardioExchange welcomes this guest post from electrophysiologists Westby Fisher and John Mandrola. This piece originally appeared on their respective blogs, Dr. Wes and Dr. John M. Slightly over a year ago, the Department of Justice (DOJ) launched an investigation of a large number of institutions regarding concerns that implantable cardiac defibrillator (ICD) procedures were performed for […]


July 14th, 2011

Rivaroxaban: The Next Non-Warfarin Oral Blood Thinner

An electrophysiologist and blogger places the recent approval of rivaroxaban in the context of the seismic changes that have taken place and that are still expected in the anticoagulant marketplace.


July 1st, 2011

AF Update: Flecainide Misinformation

John Mandrola is a cardiac electrophysiologist and blogger on matters medical and general. Here is a recent post from his blog, Dr John M. I have said that the best tool for treating atrial fibrillation (AF) is education. I still strongly believe that, perhaps more than ever. AF presents itself to people in so many different ways – from […]


May 9th, 2011

Words, ICDs, and Patient-Centered Medicine…

John Mandrola is a cardiac electrophysiologist and blogger on matters medical and general. Here is a recent post from his blog, Dr John M. Guess what made the heart rhythm newswire yesterday? It wasn’t a new medicine, or a new stent, not even a new ablation catheter, and it surely wasn’t a revolution in motivating people to exercise. It was words. […]


March 25th, 2011

The Best Tool for Treating Atrial Fibrillation

John Mandrola is a cardiac electrophysiologist and blogger on matters medical and general. Here is a recent post from his blog, Dr John M. Today, I would like to tell you about the most effective way to treat the most common heart ailment — atrial fibrillation (AF). It’s not the novel new blood-thinner, dabigatran (Pradaxa). Though it’s […]


December 23rd, 2010

John Mandrola: Looking Back at 2010 and Ahead to 2011

To celebrate the holiday season, CardioExchange asked several of our contributors to choose the 3 most important cardiology-related events of the past year and to make 3 predictions for 2011. Looking back at 2010: 1. By far, the number one heart story of 2010 was the release of the novel blood-thinning drug, dabigatran (Pradaxa), for the prevention of stroke […]


November 5th, 2010

Independent doctors?

John Mandrola is a cardiac electrophysiologist and blogger on matters medical and general. Here is a recent post from his blog Dr John M. In response to my story on how physician consolidation and hospital ownership of doctors is affecting patient referral patterns, I received an email with this attached PDF file.  (Smudges mine) It is from […]


October 20th, 2010

Dabigatran Is Approved

John Mandrola is a cardiac electrophysiologist and blogger on matters medical and general. Here is a recent post from his blog Dr John M. There can only be one cardiology story to discuss today. Tuesday, the FDA approved dabigatran (Pradaxa), an oral anticoagulant for the prevention of stroke in atrial fibrillation. Previously, the only drug approved to prevent stroke in […]


September 30th, 2010

Don’t Take My Fun Away

John Mandrorla is a cardiac electrophysiologist and blogger on matters medical and general. In a recent post to his blog Dr John M, he celebrates his enduring sense that doctoring is still a great job.


September 21st, 2010

See Everything

John Mandrola is a cardiac electrophysiologist and blogger on matters medical and general. Here is a recent post from his blog Dr John M. Do you see anything wrong with this picture? (Hint: see the right column) I guess the European electrophysiologists couldn’t wait for us in North America.  They have published their own 54,000 word Euro-specific guidance […]